AllianceBernstein’s Clover Health Investments CLOV Stock Holding History

AllianceBernstein’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$937K	Sell	398,800 -12,100	-3%	-$26.2K	﹤0.01%	2370
2025 Q4	$966K	Sell	410,900 -5,085	-1%	-$13.9K	﹤0.01%	2359
2025 Q3	$1.27M	Buy	415,985 +5,085	+1%	+$14.5K	﹤0.01%	2233
2025 Q2	$1.15M	Buy	+410,900	New	+$1.35M	﹤0.01%	2221
2023 Q2	–	Sell	-375,800	Closed	-$318K	–	3185
2023 Q1	$318K	Hold	375,800	–	–	﹤0.01%	2751
2022 Q4	$349K	Hold	375,800	–	–	﹤0.01%	2810
2022 Q3	$639K	Hold	375,800	–	–	﹤0.01%	2525
2022 Q2	$804K	Buy	+375,800	New	+$999K	﹤0.01%	2456

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AllianceBernstein's CLOV Position: Q1 2026 in Review

AllianceBernstein reduced its Clover Health Investments (CLOV) stake by 2.9% in Q1 2026, selling an estimated $26.2K and leaving 398,800 shares worth $937K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

AllianceBernstein first reported a position in CLOV in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.27M in Q3 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

AllianceBernstein held 398,800 shares of Clover Health Investments worth $937K as of Q1 2026.
AllianceBernstein sold 12,100 Clover Health Investments shares in Q1 2026, an estimated $26.2K.
Clover Health Investments made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2370 holding.
AllianceBernstein first reported a position in Clover Health Investments in Q2 2022 and has held it in 8 quarters since.
AllianceBernstein's Clover Health Investments position peaked at $1.27M in Q3 2025.
208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.